Novavax swings to profit in Q4 CEO remains optimistic despite U.S. regulatory uncertainties Shares surge over 22% after strong results Feb 26 (Reuters) - Novavax (NVAX.O), opens new tab raised its ...

Novavax reported a fourth-quarter earnings shift to a profit of 11 cents, compared to a loss of 51 cents a year ago, with revenue hitting $147 million, a 67% increase year-over-year. However, the ...

Novavax (NVAX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...

Novavax (NASDAQ:NVAX) is gearing up to announce its quarterly earnings on Thursday, 2026-02-26. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

Management provided a 2026 adjusted total revenue target of $230 million to $270 million, including $35 million to $45 million of Nuvaxovid product sales under existing orders, $40 million to $50 ...

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Thursday reported fourth-quarter earnings of $17.5 million. On a per-share basis, the Gaithersburg, Maryland-based company said ...

Novavax (NVAX) traded higher in the premarket on Thursday as the COVID-19 vaccine developer's Q4 2025 results exceeded Street forecasts for revenue and indicated full-year profitability thanks to a ...